Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
Sage Therapeutics (NASDAQ: SAGE) has announced it will host a live webcast on Tuesday, February 11, 2025 at 4:30 p.m. ET. During the webcast, the company will review its fourth quarter and full year 2024 financial results and provide recent business updates. Investors can access the webcast through the company's investor relations website at investor.sagerx.com. A replay will be available after the event and archived for up to 30 days.
Sage Therapeutics (NASDAQ: SAGE) ha annunciato che ospiterà un webcast dal vivo il martedì 11 febbraio 2025 alle 16:30 ET. Durante il webcast, l'azienda esaminerà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 e fornirà aggiornamenti recenti sull'attività. Gli investitori possono accedere al webcast attraverso il sito web delle relazioni con gli investitori dell'azienda all'indirizzo investor.sagerx.com. Una registrazione sarà disponibile dopo l'evento e archiviata per un massimo di 30 giorni.
Sage Therapeutics (NASDAQ: SAGE) ha anunciado que llevará a cabo un webcast en vivo el martes 11 de febrero de 2025 a las 4:30 p.m. ET. Durante el webcast, la compañía revisará sus resultados financieros del cuarto trimestre y del año completo 2024 y proporcionará actualizaciones recientes sobre el negocio. Los inversores pueden acceder al webcast a través del sitio web de relaciones con inversores de la compañía en investor.sagerx.com. Se dispondrá de una repetición después del evento y se archivará durante un máximo de 30 días.
Sage Therapeutics (NASDAQ: SAGE)는 2025년 2월 11일 화요일 오후 4:30 ET에 라이브 웹캐스트를 개최할 것이라고 발표했습니다. 웹캐스트 동안 회사는 2024년 4분기 및 전체 연도 재무 결과를 검토하고 최근 사업 업데이트를 제공할 예정입니다. 투자자는 회사의 투자자 관계 웹사이트인 investor.sagerx.com을 통해 웹캐스트에 액세스할 수 있습니다. 이벤트 후 재방송이 제공되며 최대 30일 동안 보관됩니다.
Sage Therapeutics (NASDAQ: SAGE) a annoncé qu'elle organisera un webcast en direct le mardi 11 février 2025 à 16h30 ET. Au cours de ce webcast, l'entreprise passera en revue ses résultats financiers du quatrième trimestre et de l'année 2024 et fournira des mises à jour récentes sur ses activités. Les investisseurs peuvent accéder au webcast via le site Web des relations avec les investisseurs de l'entreprise à l'adresse investor.sagerx.com. Un enregistrement sera disponible après l'événement et archivé pendant 30 jours maximum.
Sage Therapeutics (NASDAQ: SAGE) hat angekündigt, am Dienstag, den 11. Februar 2025 um 16:30 Uhr ET ein Live-Webcast zu veranstalten. Während des Webcasts wird das Unternehmen seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 überprüfen und aktuelle Geschäftsinformationen bereitstellen. Anleger können über die Investor-Relations-Website des Unternehmens unter investor.sagerx.com auf den Webcast zugreifen. Eine Wiederholung wird nach der Veranstaltung verfügbar sein und bis zu 30 Tage lang archiviert.
- None.
- None.
The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company committed to our mission of pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250128429244/en/
Investor Contact
Ashley Kaplowitz
Ashley.Kaplowitz@sagerx.com
Media Contact
Francesca Dellelci
Francesca.Dellelci@sagerx.com
Source: Sage Therapeutics, Inc.
FAQ
When will Sage Therapeutics (SAGE) report Q4 and full year 2024 earnings?
How can investors access SAGE's Q4 2024 earnings webcast?
How long will SAGE's Q4 2024 earnings webcast replay be available?
What will be covered in Sage Therapeutics' February 11, 2025 webcast?
